Insider Transactions in Q2 2025 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 23
2025
|
Michael Geffner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,349
-1.03%
|
$32,886
$14.79 P/Share
|
|
Apr 23
2025
|
Jay S Stout Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,925
-0.91%
|
$26,950
$14.79 P/Share
|
|
Apr 16
2025
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,321
-0.7%
|
$116,494
$14.89 P/Share
|
|
Apr 16
2025
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,993
-0.75%
|
$41,902
$14.89 P/Share
|
|
Apr 09
2025
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,094
-2.31%
|
$337,128
$12.99 P/Share
|
|
Apr 01
2025
|
Christopher Van Tuyl Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,787
+24.01%
|
-
|
|
Apr 01
2025
|
Michael Geffner Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
101,574
+30.28%
|
-
|
|
Apr 01
2025
|
Jay S Stout Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
76,181
+26.06%
|
-
|
|
Apr 01
2025
|
Melanie Gloria Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
76,181
+29.04%
|
-
|
|
Apr 01
2025
|
Peter Salzmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
265,820
+17.96%
|
-
|
|
Apr 01
2025
|
Eva Renee Barnett Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88,878
+17.79%
|
-
|
|
Apr 01
2025
|
George V Migausky Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,188
+10.55%
|
-
|
|
Apr 01
2025
|
Andrew J. Fromkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,188
+13.02%
|
-
|
|
Apr 01
2025
|
Douglas J. Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,188
+10.65%
|
-
|
|
Apr 01
2025
|
Atul Pande Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,188
+13.6%
|
-
|
|
Apr 01
2025
|
Frank Torti Director |
BUY
Grant, award, or other acquisition
|
Direct |
199,365
+19.27%
|
-
|